Neurocrine Biosciences (NBIX) Quarterly EPS earnings growth

Graphic logo of neurocrine.com (NBIX)

Adherence to strict temperature controls during drug transportation increases costs, yet the dominance of key neurology medications protects Neurocrine Biosciences (NBIX) profits from dumping. The current quarterly EPS trend visualizes this balance, where the -4.10 mark indicates the level of current yield. Stable demand for therapy supports the business, although geopolitical tensions may limit international trials and patent protection.

neurocrine.com (NBIX) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Neurocrine Biosciences (NBIX)

- market value and analyst target forecast:
Comprehensive company analysis:Neurocrine Biosciences Inc, NBIX
Manufactured product of Neurocrine Corp

This indicator captures the dynamics of earnings per share (EPS) growth, reflecting the actual pace of business capitalization. At Neurocrine Biosciences (NBIX), this growth is driven by bio-screening automation, which reduces drug development costs. By analyzing the magnitude of quarterly EPS growth, investors can see the impact of global liquidity on the asset's value. A stagnating trend signals that growth drivers have been exhausted, allowing investors to avoid overpaying for the company's fading potential.

Who Neurocrine Biosciences competes with

BIIB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Regencell|AXSM (Axsome) - Quarterly EPS earnings growth|Quarterly EPS earnings growth ACADIA Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Supernus Corp SUPN|Year-over-year earnings per share growth rate for the last twelve months CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Quarterly EPS earnings growth|HRMY: Year-over-year earnings per share growth for the last twelve months|Biohaven (BHVN) - Year-over-year earnings per share growth for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Quarterly EPS earnings growth|TRVI (Trevi Therapeutics Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Praxis Medicines (PRAX)|Year-over-year net earnings per share growth for the last 12 months AVXL (Anavex Life Sciences)|Year-over-year net earnings per share growth for the last 12 months CeriBell CBLL|Year-over-year earnings per share growth for the last twelve months Prothena Biosciences PRTA|Quarterly EPS earnings growth Alector, Inc. ALEC|ANNX - Year-over-year earnings per share growth for the last twelve months|OMER - Quarterly EPS earnings growth|Neurogene (NGNE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months AC Immune SA (ACIU)|Year-over-year net earnings per share growth for the last 12 months VYGR|Quarterly EPS earnings growth Neumora Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months scilexholding.com (SCLX)|Year-over-year net earnings per share change for the last twelve months Tevogen Bio Inc.|Year-over-year earnings per share growth for the last twelve months Alpha Cognition Inc. ACOG|Quarterly EPS earnings growth Cognition Therapeutics CGTX|IKT: Year-over-year net earnings per share growth for the last 12 months|SAVA (Cassava Sciences) - Year-over-year earnings per share growth for the last 12 months|Assertio Holdings, Inc. (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last twelve months Vistagen|Year-over-year net earnings per share growth for the last 12 months Ovid Therapeutics (OVID)|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Earnings per share growth in annualized terms for the last twelve months|Alterity Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CLNN: Year-over-year earnings per share growth for the last 12 months|pepgen.com - Quarterly EPS earnings growth|JUNS (Jupiter Neurosciences) - Year-over-year earnings per share growth for the last 12 months|Relmada (RLMD) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Quarterly EPS earnings growth|Firefly Neuroscience Inc (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical Technologies, Inc. HSDT|PASG: Quarterly EPS earnings growth|Neuphoria (NEUP) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ADXN (Addex Therapeutics)|Quarterly EPS earnings growth Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|PTIX (Protagenic Therapeutics) - Year-over-year net earnings per share trend for the last twelve months|Pasithea Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)